October 23, 2025 ⋅ 5 min reAd
Tirzepatide Safety Information
Who it’s for
Tirzepatide-based therapy may be used in clinician-guided programs for chronic weight management in appropriate patients, alongside nutrition and physical activity changes.
Who should not use
A clinician must screen for contraindications and risk factors. Patients should disclose current medications, past adverse reactions, pregnancy status, and relevant family history.
Warnings
Patients must know what symptoms require immediate medical attention (severe or persistent vomiting, dehydration signs, severe abdominal pain, allergic reactions), and how to reach your clinical support.
Compounded disclosures
If compounded: state clearly that compounded drugs are not FDA-approved and are not evaluated by the FDA for safety, effectiveness, or quality prior to marketing.
How to get help
If medication is provided in a vial, dosing errors are a known risk when patients measure doses themselves. Provide a step-by-step injection basics guide, measurement safety reminders, and “contact your clinician if unsure” instructions.
.webp)
